GÖRG advises Ufenau on the investment in Dr. Niedermaier Pharma Group

Frankfurt am Main, 19.07.2022

GÖRG Partnerschaft von Rechtsanwälten mbB has advised Ufenau Capital Partners on the investment in the Dr. Niedermaier Pharma Group ("Dr. NIEDERMAIER"). Founded in 1939, Dr. NIEDERMAIER is a leading producer and supplier of organic nutritional supplements and natural cosmetics with headquarters in Hohenbrunn near Munich (DE) and in Appenzell (CH). 

With the investment in Dr. NIEDERMAIER, Ufenau aims to establish a leading group of companies in the field of nutritional supplements in Europe. Together, the firm’s market position will be expanded through strategic acquisitions, extension of the product portfolio and geographical reach. As part of the transaction, the former shareholders will reinvest in the newly formed group and will continue their engagement.

With over 50 employees and numerous cooperation partners, Dr. NIEDERMAIER produces and distributes throughout Europe nutritional supplements, natural cosmetics and beauty liquids in the premium segment based on the patented "Regulatessence". The "Regulatessence" is a highly concentrated, plant-based enzyme digest, which is manufactured in the firm’s own production facility in Hohenbrunn by means of a three-stage cascade fermentation of nuts, fruits and vegetables.

A GÖRG team led by Frankfurt partner Dr Tobias Fenck provided legal and tax law advice to Ufenau Capital Partners on the investment. The Swiss investor group regularly relies on the expertise of GÖRG's experienced PE specialist for transactions in the German market. 
 

Advisors Ufenau Capital Partners

GÖRG Partnerschaft von Rechtsanwälten mbB
Dr. Tobias Fenck (Lead, Partner, Corporate/M&A, Frankfurt am Main)
Dr. Andrea Zimmermann (Partner, Corporate/M&A, Cologne)
Dr. Adalbert Rödding, LL.M. (Partner, Tax, Cologne)
Dr. Oliver Spieker (Partner, IP/IT Commercial, Berlin)
Dr. Wolf zur Nieden (Partner, Real Estate, Cologne)
Dr. Dirk Freihube (Partner, Labour, Frankfurt am Main)
Dr. Holger Dann, LL.M. (Counsel, Tax, Cologne)
Robert Schindler (Associated Partner, Coporate / M&A, Frankfurt am Main)
Dilan Mienert (Associate, IP/IT Commercial, Berlin)
Florian Mayer, M.A. (Associate, Corporate/M&A, Frankfurt am Main)
Philipp Müller (Associate, Corporate/M&A, Frankfurt am Main)
 

About Ufenau Capital Partners

Ufenau Capital Partners is a privately-owned Swiss Investor Group headquartered at Lake Zurich which advises private and institutional investors with their investments in private equity. Ufenau Capital Partners is focused on investments in fast-growing service companies in German-speaking Europe, Iberia and the Benelux region and invests in Education & Lifestyle, Business Services, Healthcare and Financial Services sectors. Since 2011, Ufenau invested in over 250 service companies in Europe. Through a renowned group of experienced Industry Partners (owners, CEOs, CFOs), Ufenau has an active value-adding investment approach at eye-level with entrepreneurs and managers. Ufenau raised its seventh flagship fund in Q1 2022 with a volume of EUR 1.0bn and advises capital of EUR 2.5bn.

 Newsletter Icon

We inform you about current legal developments in the areas relevant to you.

Subscribe to our Newsletter

Anmedlung Newsletter

Einige der von uns gesetzten Cookies dienen dazu, bestimmte Funktionen unserer Webseiten zu ermöglichen, insbesondere zur Steuerung des Cookie-Banners (damit dieses bei Ihren erneuten Besuchen nicht immer wieder angezeigt wird). Diese Cookies enthalten keine personenbezogenen Daten, insbesondere nicht Ihre IP-Adresse. Andere Cookies, die zu Analysezwecken gesetzt werden (siehe hierzu auch den Abschnitt „Web-Analyse-Tools“), helfen uns zu verstehen, wie Besucher mit unseren Webseiten interagieren. Diese Cookies dienen dazu, die Nutzung unserer Webseiten statistisch zu erfassen und zum Zwecke der Optimierung unseres Angebotes auszuwerten. Die Analyse-Cookies werden bis zu 13 Monate gespeichert.

Save Cancel OK Tracking ablehnen Datenschutzerklärung